or Try an Advanced Search...

    Technical Analysis for OCEA - Ocean Biomedical, Inc.

    Grade Last Price % Change Price Change
    F 0.89 1.44% 0.01
    OCEA closed up 1.44 percent on Friday, November 1, 2024, on 25 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical OCEA trend table...
    Date Alert Name Type % Chg
    Lower Bollinger Band Walk Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Stochastic Buy Signal Bullish 1.44%
    Lower Bollinger Band Touch Weakness 1.44%
    Oversold Stochastic Weakness 1.44%
    Oversold Stochastic Weakness 2.25%
    Gapped Up Strength -3.30%
    Oversold Stochastic Weakness -3.30%
    20 DMA Resistance Bearish -3.07%
    Older End-of-Day Signals for OCEA ...

       Recent Intraday Alerts

    Alert Time
    Up 2% about 20 hours ago
    60 Minute Opening Range Breakout about 23 hours ago
    Rose Above Previous Day's High about 23 hours ago
    Up 1% about 23 hours ago
    Lower Bollinger Band Support about 23 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    OCEA Chart by TradingView
    Basic chart:

    Profile

    Ocean Biomedical, Inc. is a Providence, Rhode Island-based biopharma company with an innovative business model that accelerates the development and commercialization of scientifically compelling assets from research universities and medical centers. Ocean Biomedical deploys the funding and expertise to move new therapeutic candidates efficiently from the laboratory to the clinic, to the world. Ocean Biomedical is currently developing five promising discoveries that have the potential to achieve life-changing outcomes in lung cancer, brain cancer, pulmonary fibrosis, and the prevention and treatment of malaria. The Ocean Biomedical team is working on solving some of the world’s toughest problems, for the people who need it most.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Lung Cancer Pulmonary Fibrosis Malaria Brain Cancer Treatment Of Malaria

    Is OCEA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 22 Ocean Biomedical receives Nasdaq’s delisting letter
    Oct 22 Ocean Biomedical, Inc. Announces Receipt of Nasdaq Staff Determination Letter
    Oct 1 Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Publication of New Data Deepening Understanding of Novel Cancer Immunotherapy Treatment Approach Targeting CHI3L1 and its Ability to Inhibit Anti-tumor and Related Tissue Remodeling Responses
    Aug 27 Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Issued for PfGARP Malaria Antibodies Central to Company’s Malaria Treatment and Prevention Platforms
    Aug 23 Ocean Biomedical receives non-compliance notice from Nasdaq
    Jun 5 Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positive Immunogenicity Results from Their Lead Checkpoint Modifier-Containing Immunotherapy, VRON-0200, for HBV Functional Cure, at EASL 2024
    May 30 Ocean Biomedical gets non-compliance notice from Nasdaq
    May 30 Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
    May 16 Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease
    See more OCEA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 7.79
    52 Week Low 0.52
    Average Volume 58,803
    200-Day Moving Average 1.53
    50-Day Moving Average 0.97
    20-Day Moving Average 0.95
    10-Day Moving Average 0.93
    Average True Range 0.07
    RSI (14) 42.20
    ADX 20.2
    +DI 19.49
    -DI 18.36
    Chandelier Exit (Long, 3 ATRs) 0.94
    Chandelier Exit (Short, 3 ATRs) 1.05
    Upper Bollinger Bands 1.05
    Lower Bollinger Band 0.84
    Percent B (%b) 0.22
    BandWidth 21.99
    MACD Line -0.02
    MACD Signal Line -0.01
    MACD Histogram -0.0093
    Fundamentals Value
    Market Cap 30.32 Million
    Num Shares 34.1 Million
    EPS -2.55
    Price-to-Earnings (P/E) Ratio -0.35
    Price-to-Sales 0.00
    Price-to-Book 100.67
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.97
    Resistance 3 (R3) 0.97 0.93 0.96
    Resistance 2 (R2) 0.93 0.91 0.93 0.96
    Resistance 1 (R1) 0.91 0.90 0.92 0.92 0.95
    Pivot Point 0.88 0.88 0.88 0.88 0.88
    Support 1 (S1) 0.85 0.85 0.86 0.86 0.83
    Support 2 (S2) 0.82 0.84 0.82 0.82
    Support 3 (S3) 0.80 0.82 0.82
    Support 4 (S4) 0.81